{
  "diffs": [
    {
      "fromVersion": "1.0",
      "toVersion": "2.0",
      "name": "ARGO Clinical Submission",
      "data": [
        [
          "donor.donor_submitter_id",
          {
            "left": {
              "name": "donor_submitter_id",
              "displayName": "Submitter Donor ID",
              "valueType": "string",
              "description": "Unique identifier for donor; assigned by data provider",
              "meta": {
                "key": true
              },
              "restrictions": {
                "script": "field.length > 5"
              }
            },
            "right": {
              "name": "donor_submitter_id",
              "valueType": "string",
              "description": "Unique identifier for donor; assigned by data provider",
              "meta": {
                "key": true
              },
              "restrictions": {
                "script": "THIS WAS UPDATED"
              }
            },
            "diff": {
              "displayName": {
                "type": "deleted",
                "data": "Submitter Donor ID"
              },
              "restrictions": {
                "script": {
                  "type": "updated",
                  "data": "THIS WAS UPDATED"
                }
              }
            }
          }
        ],
        [
          "donor.gender",
          {
            "left": {
              "name": "gender",
              "valueType": "string",
              "description": "Donor Biological Sex",
              "restrictions": {
                "codeList": ["Male", "Female", "Other"]
              }
            },
            "right": {
              "name": "gender",
              "valueType": "string",
              "description": "Donor Biological Sex",
              "restrictions": {
                "codeList": ["Male", "Female", "Undeclared"]
              }
            },
            "diff": {
              "restrictions": {
                "codeList": {
                  "type": "updated",
                  "data": {
                    "added": ["Undeclared"],
                    "deleted": ["Other"]
                  }
                }
              }
            }
          }
        ]
      ]
    }
  ],
  "dictionaries": [
    {
      "schemas": [
        {
          "name": "sample_registration",
          "description": "Collection of elements required to register the required Donor-Specimen-Sample data to the ARGO Platform. Registration of samples is required before genomic and clinical data submission can proceed.",
          "fields": [
            {
              "name": "program_id",
              "valueType": "string",
              "description": "Unique identifier of the ARGO program.",
              "restrictions": {
                "required": true
              }
            },
            {
              "name": "submitter_donor_id",
              "valueType": "string",
              "description": "Unique identifier of the donor, assigned by the data provider.",
              "restrictions": {
                "required": true,
                "regex": "[A-Za-z0-9\\-\\._]{1,64}"
              }
            },
            {
              "name": "gender",
              "valueType": "string",
              "description": "Description of the donor self-reported gender. Gender is described as the assemblage of properties that distinguish people on the basis of their societal roles.",
              "restrictions": {
                "required": true,
                "codeList": ["Male", "Female", "Other"]
              }
            },
            {
              "name": "submitter_specimen_id",
              "valueType": "string",
              "description": "Unique identifier of the specimen, assigned by the data provider.",
              "restrictions": {
                "required": true,
                "regex": "[A-Za-z0-9\\-\\._]{1,64}"
              }
            },
            {
              "name": "specimen_tissue_source",
              "valueType": "string",
              "description": "Tissue source of the biospecimen.",
              "restrictions": {
                "required": true,
                "codeList": [
                  "Blood derived",
                  "Blood derived - bone marrow",
                  "Blood derived - peripheral blood",
                  "Bone marrow",
                  "Buccal cell",
                  "Lymph node",
                  "Solid tissue",
                  "Plasma",
                  "Serum",
                  "Urine",
                  "Cerebrospinal fluid",
                  "Sputum",
                  "Other",
                  "Pleural effusion",
                  "Mononuclear cells from bone marrow",
                  "Saliva",
                  "Skin"
                ]
              }
            },
            {
              "name": "tumour_normal_designation",
              "valueType": "string",
              "description": "Description of specimens tumour/normal status for data processing.",
              "restrictions": {
                "required": true,
                "codeList": ["Normal", "Tumour"]
              },
              "meta": {
                "core": true
              }
            },
            {
              "name": "specimen_type",
              "valueType": "string",
              "description": "Description of the kind of specimen that was collected with respect to tumour/normal tissue origin.",
              "restrictions": {
                "required": true,
                "codeList": [
                  "Normal",
                  "Normal - tissue adjacent to primary tumour",
                  "Primary tumour",
                  "Primary tumour - adjacent to normal",
                  "Primary tumour - additional new primary",
                  "Recurrent tumour",
                  "Metastatic tumour",
                  "Metastatic tumour - metastasis local to lymph node",
                  "Metastatic tumour - metastasis to distant location",
                  "Metastatic tumour - additional metastatic",
                  "Xenograft - derived from primary tumour",
                  "Xenograft - derived from tumour cell line",
                  "Cell line - derived from xenograft tumour",
                  "Cell line - derived from tumour",
                  "Cell line - derived from normal"
                ]
              },
              "meta": {
                "core": true
              }
            },
            {
              "name": "submitter_sample_id",
              "valueType": "string",
              "description": "Unique identifier of the sample, assigned by the data provider.",
              "restrictions": {
                "required": true,
                "regex": "[A-Za-z0-9\\-\\._]{1,64}"
              }
            },
            {
              "name": "sample_type",
              "valueType": "string",
              "description": "Description of the type of molecular sample used for testing.",
              "restrictions": {
                "required": true,
                "codeList": [
                  "Total DNA",
                  "Amplified DNA",
                  "ctDNA",
                  "Other DNA enrichments",
                  "Total RNA",
                  "Ribo-Zero RNA",
                  "polyA+ RNA",
                  "Other RNA fractions"
                ]
              }
            }
          ]
        },
        {
          "name": "donor",
          "description": "The collection of data elements related to a specific donor in a specific ICGC-ARGO program.",
          "fields": [
            {
              "name": "program_id",
              "valueType": "string",
              "description": "Unique identifier of the ARGO program.",
              "restrictions": {
                "required": true
              }
            },
            {
              "description": "Unique identifier of the donor, assigned by the data provider.",
              "name": "submitter_donor_id",
              "restrictions": {
                "required": true,
                "regex": "[A-Za-z0-9\\-\\._]{1,64}"
              },
              "valueType": "string"
            },
            {
              "description": "Donors last known state of living or deceased.",
              "name": "vital_status",
              "restrictions": {
                "codeList": ["Alive", "Deceased", "Not reported", "Unknown"],
                "required": true
              },
              "valueType": "string"
            },
            {
              "description": "Description of the cause of a donor's death.",
              "name": "cause_of_death",
              "restrictions": {
                "codeList": ["Died of cancer", "Died of other reasons", "Not reported", "Unknown"]
              },
              "valueType": "string"
            },
            {
              "description": "Interval of how long the donor has survived since primary diagnosis, in days.",
              "meta": {
                "units": "days"
              },
              "name": "survival_time",
              "valueType": "integer"
            }
          ]
        },
        {
          "name": "primary_diagnosis",
          "description": "The collection of data elements related to a donor's primary diagnosis. The primary diagnosis is the first diagnosed case of cancer in a donor.",
          "fields": [
            {
              "name": "program_id",
              "valueType": "string",
              "description": "Unique identifier of the ARGO program.",
              "restrictions": {
                "required": true
              }
            },
            {
              "name": "submitter_donor_id",
              "valueType": "string",
              "description": "Unique identifier of the donor, assigned by the data provider.",
              "restrictions": {
                "required": true,
                "regex": "[A-Za-z0-9\\-\\._]{1,64}"
              }
            },
            {
              "name": "age_at_diagnosis",
              "valueType": "integer",
              "description": "Age that the donor was first diagnosed with cancer, in years.",
              "restrictions": {
                "required": true
              },
              "meta": {
                "units": "years"
              }
            },
            {
              "name": "cancer_type_code",
              "valueType": "string",
              "description": "The code to represent the cancer type using the WHO ICD-10 code (https://icd.who.int/browse10/2016/en#/) classification.",
              "restrictions": {
                "required": true,
                "regex": "[A-Z]{1}[0-9]{2}.[0-9]{0,3}[A-Z]{0,1}$"
              }
            },
            {
              "name": "tumour_staging_system",
              "valueType": "string",
              "description": "Specify the tumour staging system used to stage the cancer at the time of primary diagnosis (prior to treatment).",
              "restrictions": {
                "required": true,
                "codeList": ["Binet", "Rai", "FIGO", "Ann Arbor", "Murphy", "Lugano"]
              }
            },
            {
              "name": "clinical_stage_group",
              "description": "Stage group of the tumour, as assigned by the reporting tumour_staging_system, that indicates the overall prognostic tumour stage (ie. Stage I, Stage II, Stage III etc.).",
              "valueType": "string"
            },
            {
              "name": "stage_suffix",
              "description": "If necessary, use this field to add any applicable stage suffixes. Stage suffixes may apply to certain staging systems such as Ann Arbour staging system where the four stages are divided into 4 categories (A, B, X and E).",
              "valueType": "string"
            },
            {
              "name": "clinical_t_category",
              "description": "The code to represent the extent of the primary tumour (T) based on evidence obtained from clinical assessment parameters determined at time of primary diagnosis and prior to treatment, according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.",
              "valueType": "string"
            },
            {
              "name": "clinical_n_category",
              "description": "The code to represent the stage of cancer defined by which is the extent of the regional lymph node (N) involvement for the cancer based on evidence obtained from clinical assessment parameters determined at time of primary diagnosis and prior to treatment, according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.",
              "valueType": "string"
            },
            {
              "name": "clinical_m_category",
              "description": "The code to represent the stage of cancer defined bythe extent of the distant metastasis (M) for the cancer based on evidence obtained from clinical assessment parameters determined at time of primary diagnosis and prior to treatment, according to criteria based on multiple editions of the AJCC's Cancer Staging Manual. MX is NOT a valid category and cannot be assigned.",
              "valueType": "string"
            },
            {
              "name": "number_lymph_nodes_examined",
              "description": "The total number of lymph nodes tested for the presence of cancer.",
              "valueType": "integer"
            },
            {
              "name": "presenting_symptoms",
              "description": "Indicate presenting symptoms at time of primary diagnosis.",
              "valueType": "string",
              "restrictions": {
                "codeList": ["Back Pain", "Nausea", "None", "Unknown", "Weight Loss"]
              }
            },
            {
              "name": "menopause_status",
              "description": "Indicate the menopause status of the patient at the time of primary diagnosis.",
              "valueType": "string",
              "restrictions": {
                "codeList": ["Perimenopausal", "Postmenopausal", "Premenopausal", "Unknown"]
              }
            }
          ]
        },
        {
          "name": "specimen",
          "description": "The collection of data elements related to a donor's specimen. A specimen is any material sample taken for testing, diagnostic or research purposes.",
          "fields": [
            {
              "name": "program_id",
              "valueType": "string",
              "description": "Unique identifier of the ARGO program.",
              "restrictions": {
                "required": true
              }
            },
            {
              "name": "submitter_donor_id",
              "description": "Unique identifier of the donor, assigned by the data provider.",
              "valueType": "string",
              "restrictions": {
                "required": true,
                "regex": "[A-Za-z0-9\\-\\._]{1,64}"
              }
            },
            {
              "name": "submitter_specimen_id",
              "description": "Unique identifier of the specimen, assigned by the data provider.",
              "valueType": "string",
              "restrictions": {
                "required": true,
                "regex": "[A-Za-z0-9\\-\\._]{1,64}"
              }
            },
            {
              "name": "specimen_acquisition_interval",
              "description": "Interval between primary diagnosis and specimen acquisition, in days.",
              "valueType": "integer",
              "restrictions": {
                "required": true
              },
              "meta": {
                "units": "days"
              }
            },
            {
              "name": "anatomic_location_of_specimen_collection",
              "description": "Anatomic location of a specimen when it was collected.",
              "valueType": "string",
              "restrictions": {
                "required": true,
                "codeList": ["Muscle", "Other", "Wrist"]
              }
            },
            {
              "name": "central_pathology_confirmed",
              "description": "Indicate whether the histologic description of tissue or cells was confirmed by a pathology review of frozen or formalin fixed slide(s) completed after the diagnostic pathology review of the tumour sample used to extract analyte(s).",
              "valueType": "string",
              "restrictions": {
                "required": true,
                "codeList": ["Yes", "No", "Unknown", "Not reported"]
              }
            },
            {
              "name": "tumour_histological_type",
              "description": "The code to represent the histology (morphology) of neoplasms that is usually obtained from a pathology report, according to the International Classification of Diseases for Oncology, 3rd Edition (WHO ICD-O-3).",
              "valueType": "string",
              "restrictions": {
                "required": true,
                "regex": "M-[0-9]{4}/[0-9]{2}$"
              }
            },
            {
              "name": "tumour_grading_system",
              "description": "Specify the tumour staging system used to assess the description of a tumour based on how abnormal the tumour cells and the tumour tissue look under a microscope. Tumour grade is an indicator of how quickly a tumour is likely to  grow.",
              "valueType": "string",
              "restrictions": {
                "required": true,
                "codeList": [
                  "Default",
                  "Gleason",
                  "Nottingham",
                  "Brain cancer",
                  "ISUP",
                  "Lymphoid neoplasms"
                ]
              }
            },
            {
              "name": "tumour_grade",
              "description": "Grade of the tumour as assigned by the reporting tumour_grading_system.",
              "valueType": "string",
              "restrictions": {
                "required": true
              }
            },
            {
              "name": "tumour_staging_system",
              "description": "Specify the tumour staging system used to assess the cancer at the time the tumour specimen was resected. Pathological classification is based on the clinical stage information (acquired before treatment) and supplemented/modified by operative findings and pathological evaluation of the resected specimen.",
              "valueType": "string",
              "restrictions": {
                "required": true,
                "codeList": ["Binet", "Rai", "FIGO", "Ann Arbor", "Murphy", "Lugano"]
              }
            },
            {
              "name": "pathological_stage_group",
              "description": "Specify the tumour stage, based on tumor_staging_system, used to assess the cancer at the time the tumour specimen was resected.",
              "valueType": "string",
              "restrictions": {
                "required": true
              }
            },
            {
              "name": "pathological_t_category",
              "description": "The code to represent the stage of cancer defined by the size or contiguous extension of the primary tumour (T), according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.",
              "valueType": "string"
            },
            {
              "name": "pathological_n_category",
              "description": "The code to represent the stage of cancer defined by whether or not the cancer has reached nearby lymph nodes (N), according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.",
              "valueType": "string"
            },
            {
              "name": "pathological_m_category",
              "description": "The code to represent the stage of cancer defined by whether there are distant metastases (M), meaning spread of cancer to other parts of the body, according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.",
              "valueType": "string"
            },
            {
              "name": "percent_tumour_cells",
              "description": "Indicate a value, in decimals, that represents the percentage of infiltration by tumour cells in a specimen.",
              "valueType": "number",
              "restrictions": {
                "required": true
              }
            },
            {
              "name": "percent_proliferating_cells",
              "description": "Indicate a value, in decimals, that represents the count of proliferating cells determined during pathologic review of the specimen.",
              "valueType": "number",
              "restrictions": {
                "required": true
              }
            },
            {
              "name": "percent_inflammatory_tissue",
              "description": "Indicate a value, in decimals, that represents local response to cellular injury, marked by capillary dilatation, edema and leukocyte infiltration; clinically, inflammation is manifest by redness, heat, pain, swelling and loss of function, with the need to heal damaged tissue.",
              "valueType": "number",
              "restrictions": {
                "required": true
              }
            },
            {
              "name": "percent_stromal_cells",
              "description": "Indicate a value, in decimals, that represents the percentage of reactive cells that are present in a malignant tumour specimen but are not malignant such as fibroblasts, vascular structures, etc.",
              "valueType": "number",
              "restrictions": {
                "required": true
              }
            },
            {
              "name": "percent_necrosis",
              "description": "Indicate a value, in decimals, that represents the percentage of cell death in a malignant tumour specimen.",
              "valueType": "number",
              "restrictions": {
                "required": true
              }
            }
          ]
        },
        {
          "name": "follow_up",
          "description": "The collection of data elements related to a specific follow up visit to a donor. A follow up is defined as any point of contact with a patient after diagnosis.",
          "fields": [
            {
              "name": "program_id",
              "valueType": "string",
              "description": "Unique identifier of the ARGO program.",
              "restrictions": {
                "required": true
              }
            },
            {
              "description": "Unique identifier of the donor, assigned by the data provider.",
              "name": "submitter_donor_id",
              "valueType": "string",
              "restrictions": {
                "required": true,
                "regex": "[A-Za-z0-9\\-\\._]{1,64}"
              }
            },
            {
              "description": "Unique identifier for a follow-up event in a donors clincal record, assigned by the data provider.",
              "name": "submitter_follow_up_id",
              "valueType": "string",
              "restrictions": {
                "required": true,
                "regex": "[A-Za-z0-9\\-\\._]{1,64}"
              }
            },
            {
              "description": "Interval from the primary diagnosis date to the follow up date, in days.",
              "name": "interval_of_followup",
              "valueType": "integer",
              "restrictions": {
                "required": true
              },
              "meta": {
                "core": true,
                "units": "days"
              }
            },
            {
              "description": "Donor's disease status at time of follow-up.",
              "name": "disease_status_at_followup",
              "valueType": "string",
              "restrictions": {
                "required": true,
                "codeList": [
                  "Complete remission",
                  "Distant progression",
                  "Loco-regional progression ",
                  "No evidence of disease",
                  "Partial remission",
                  "Relapse",
                  "Stable"
                ]
              },
              "meta": {
                "core": true
              }
            },
            {
              "description": "Donor's relapse type if disease status at followup was progression or relapse.",
              "name": "relapse_type",
              "valueType": "string",
              "restrictions": {
                "codeList": [
                  "Distant recurrence/metastasis",
                  "Local recurrence",
                  "Local recurrence and distant metastasis",
                  "Progression (liquid tumours)"
                ]
              },
              "meta": {
                "core": true
              }
            },
            {
              "description": "If the donor was clinically disease free following primary treatment and then relapse or progression (for liquid tumours) occurred afterwards, then this field will indicate the length of disease free interval, in days.",
              "name": "relapse_interval",
              "valueType": "integer",
              "restrictions": {
                "script": "function validate() {\r\n  var result = { valid: true, message: \"depends on disaease_status_at_followup being relapse\" };\r\n  return result;\r\n}\r\n\r\nvalidate();"
              },
              "meta": {
                "core": true,
                "units": "days"
              }
            },
            {
              "description": "Method(s) used to confirm the patient's progression disease status.",
              "name": "method_of_progression_status",
              "valueType": "string",
              "restrictions": {
                "script": "function validate() {\r\n  var result = { valid: true, message: \"depends on disaease_status_at_followup being progression or relapse\" };\r\n  return result;\r\n}\r\n\r\nvalidate();",
                "codeList": [
                  "Autopsy",
                  "Biomarker in liquid biopsy (e.g. tumor marker in blood or urine)",
                  "Biopsy",
                  "Blood draw",
                  "Bone marrow aspirate",
                  "Core biopsy",
                  "Cystoscopy",
                  "Cytology",
                  "Debulking",
                  "Diagnostic imaging",
                  "Dilation and curettage procedure",
                  "Enucleation",
                  "Excisional biopsy",
                  "Fine needle aspiration",
                  "Imaging",
                  "Incisional biopsy",
                  "Laparoscopy",
                  "Laparotomy",
                  "Other",
                  "Pap Smear",
                  "Pathologic review",
                  "Physical exam",
                  "Surgical resection",
                  "Thoracentesis",
                  "Ultrasound guided biopsy"
                ]
              },
              "meta": {
                "core": true
              }
            },
            {
              "description": "The anatomic site where disease progression or recurrence occurred.",
              "name": "anatomic_site_progression_or_recurrences",
              "valueType": "string",
              "restrictions": {
                "script": "function validate() {\r\n  var result = { valid: true, message: \"depends on disaease_status_at_followup being progression or relapse\" };\r\n  return result;\r\n}\r\n\r\nvalidate();",
                "codeList": [
                  "Abdomen",
                  "Abdominal wall",
                  "Acetabulum",
                  "Adenoid",
                  "Adipose",
                  "Adrenal",
                  "Alveolar ridge",
                  "Amniotic fluid",
                  "Ampulla of vater",
                  "Anal sphincter",
                  "Ankle",
                  "Anorectum",
                  "Antecubital fossa",
                  "Antrum",
                  "Anus",
                  "Aorta",
                  "Aortic body",
                  "Appendix",
                  "Aqueous fluid",
                  "Arm",
                  "Artery",
                  "Ascending colon",
                  "Ascending colon hepatic flexure",
                  "Auditory canal",
                  "Autonomic nervous system",
                  "Axilla",
                  "Back",
                  "Bile duct",
                  "Bladder",
                  "Blood",
                  "Blood vessel",
                  "Bone",
                  "Bone marrow",
                  "Bowel",
                  "Brain",
                  "Brain stem",
                  "Breast",
                  "Broad ligament",
                  "Bronchiole",
                  "Bronchus",
                  "Brow",
                  "Buccal cavity",
                  "Buccal mucosa",
                  "Buttock",
                  "Calf",
                  "Capillary",
                  "Cardia",
                  "Carina",
                  "Carotid artery",
                  "Carotid body",
                  "Cartilage",
                  "Cecum",
                  "Cell-line",
                  "Central nervous system",
                  "Cerebellum",
                  "Cerebral cortex",
                  "Cerebrospinal fluid",
                  "Cerebrum",
                  "Cervical spine",
                  "Cervix",
                  "Chest",
                  "Chest wall",
                  "Chin",
                  "Clavicle",
                  "Clitoris",
                  "Colon",
                  "Colon - mucosa only",
                  "Common duct",
                  "Conjunctiva",
                  "Connective tissue",
                  "Dermal",
                  "Descending colon",
                  "Diaphragm",
                  "Duodenum",
                  "Ear",
                  "Ear canal",
                  "Ear, pinna (external)",
                  "Effusion",
                  "Elbow",
                  "Endocrine gland",
                  "Epididymis",
                  "Epidural space",
                  "Esophageal; distal",
                  "Esophageal; mid",
                  "Esophageal; proximal",
                  "Esophagogastric junction",
                  "Esophagus",
                  "Esophagus - mucosa only",
                  "Eye",
                  "Fallopian tube",
                  "Femoral artery",
                  "Femoral vein",
                  "Femur",
                  "Fibroblasts",
                  "Fibula",
                  "Finger",
                  "Floor of mouth",
                  "Fluid",
                  "Foot",
                  "Forearm",
                  "Forehead",
                  "Foreskin",
                  "Frontal cortex",
                  "Frontal lobe",
                  "Fundus of stomach",
                  "Gallbladder",
                  "Ganglia",
                  "Gastroesophageal junction",
                  "Gastrointestinal tract",
                  "Groin",
                  "Gum",
                  "Hand",
                  "Hard palate",
                  "Head - face or neck, nos",
                  "Head & neck",
                  "Heart",
                  "Hepatic",
                  "Hepatic duct",
                  "Hepatic flexure",
                  "Hepatic vein",
                  "Hip",
                  "Hippocampus",
                  "Humerus",
                  "Hypopharynx",
                  "Ileum",
                  "Ilium",
                  "Index finger",
                  "Ischium",
                  "Islet cells",
                  "Jaw",
                  "Jejunum",
                  "Joint",
                  "Kidney",
                  "Knee",
                  "Lacrimal gland",
                  "Large bowel",
                  "Laryngopharynx",
                  "Larynx",
                  "Leg",
                  "Leptomeninges",
                  "Ligament",
                  "Lip",
                  "Liver",
                  "Lumbar spine",
                  "Lung",
                  "Lymph node",
                  "Lymph node(s) axilla",
                  "Lymph node(s) cervical",
                  "Lymph node(s) distant",
                  "Lymph node(s) epitrochlear",
                  "Lymph node(s) femoral",
                  "Lymph node(s) hilar",
                  "Lymph node(s) iliac-common",
                  "Lymph node(s) iliac-external",
                  "Lymph node(s) inguinal",
                  "Lymph node(s) internal mammary",
                  "Lymph node(s) mammary",
                  "Lymph node(s) mesenteric",
                  "Lymph node(s) occipital",
                  "Lymph node(s) paraaortic",
                  "Lymph node(s) parotid",
                  "Lymph node(s) pelvic",
                  "Lymph node(s) popliteal",
                  "Lymph node(s) regional",
                  "Lymph node(s) retroperitoneal",
                  "Lymph node(s) scalene",
                  "Lymph node(s) splenic",
                  "Lymph node(s) subclavicular",
                  "Lymph node(s) submandibular",
                  "Lymph node(s) supraclavicular",
                  "Lymph nodes(s) mediastinal",
                  "Mandible",
                  "Maxilla",
                  "Mediastinal soft tissue",
                  "Mediastinum",
                  "Mesentery",
                  "Mesothelium",
                  "Middle finger",
                  "Mitochondria",
                  "Muscle",
                  "Nails",
                  "Nasal cavity",
                  "Nasal soft tissue",
                  "Nasopharynx",
                  "Neck",
                  "Nerve",
                  "Nerve(s) cranial",
                  "Occipital cortex",
                  "Ocular orbits",
                  "Omentum",
                  "Oral cavity",
                  "Oral cavity - mucosa only",
                  "Oropharynx",
                  "Other",
                  "Ovary",
                  "Palate",
                  "Pancreas",
                  "Paraspinal ganglion",
                  "Parathyroid",
                  "Parotid gland",
                  "Patella",
                  "Pelvis",
                  "Penis",
                  "Pericardium",
                  "Periorbital soft tissue",
                  "Peritoneal cavity",
                  "Peritoneum",
                  "Pharynx",
                  "Pineal",
                  "Pineal gland",
                  "Pituitary gland",
                  "Placenta",
                  "Pleura",
                  "Popliteal fossa",
                  "Prostate",
                  "Pylorus",
                  "Rectosigmoid junction",
                  "Rectum",
                  "Retina",
                  "Retro-orbital region",
                  "Retroperitoneum",
                  "Rib",
                  "Ring finger",
                  "Round ligament",
                  "Sacrum",
                  "Salivary gland",
                  "Scalp",
                  "Scapula",
                  "Sciatic nerve",
                  "Scrotum",
                  "Seminal vesicle",
                  "Shoulder",
                  "Sigmoid colon",
                  "Sinus",
                  "Sinus(es), maxillary",
                  "Skeletal muscle",
                  "Skin",
                  "Skull",
                  "Small bowel",
                  "Small bowel - mucosa only",
                  "Small finger",
                  "Soft tissue",
                  "Spinal column",
                  "Spinal cord",
                  "Spleen",
                  "Splenic flexure",
                  "Sternum",
                  "Stomach",
                  "Stomach - mucosa only",
                  "Subcutaneous tissue",
                  "Synovium",
                  "Temporal cortex",
                  "Tendon",
                  "Testis",
                  "Thigh",
                  "Thoracic spine",
                  "Thorax",
                  "Throat",
                  "Thumb",
                  "Thymus",
                  "Thyroid",
                  "Tibia",
                  "Tongue",
                  "Tonsil",
                  "Tonsil (pharyngeal)",
                  "Trachea / major bronchi",
                  "Transverse colon",
                  "Trunk",
                  "Umbilical cord",
                  "Ureter",
                  "Urethra",
                  "Urinary tract",
                  "Uterus",
                  "Uvula",
                  "Vagina",
                  "Vas deferens",
                  "Vein",
                  "Venous",
                  "Vertebra",
                  "Vulva",
                  "White blood cells",
                  "Wrist"
                ]
              },
              "meta": {
                "core": true
              }
            },
            {
              "description": "Specify the tumour staging system used to stage the cancer at time of retreatment for recurrence or disease progression. This may be represented as rTNM in the medical report.",
              "name": "recurrence_tumour_staging_system",
              "valueType": "string",
              "restrictions": {
                "script": "function validate() {\r\n  var result = { valid: true, message: \"depends on disaease_status_at_followup being progression or relapse\" };\r\n  return result;\r\n}\r\n\r\nvalidate();",
                "codeList": [
                  "Binet",
                  "Rai",
                  "FIGO",
                  "Ann Arbor",
                  "Murphy",
                  "Lugano",
                  "AJCC 8th Edition",
                  "AJCC 7th Edition",
                  "AJCC 6th Edition",
                  "AJCC 5th Edition",
                  "AJCC 4th Edition",
                  "AJCC 3rd Edition",
                  "AJCC 2nd Edition",
                  "AJCC 1st Edition"
                ]
              },
              "meta": {
                "core": true
              }
            },
            {
              "name": "recurrence_t_category",
              "description": "The code to represent the extent of the primary tumour (T) based on evidence obtained from clinical assessment parameters determined after treatment for patients receiving systemic and/or radiation therapy alone or as a component of their initial treatment, or as neoadjuvant therapy before planned surgery, according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.",
              "valueType": "string",
              "restrictions": {
                "script": "function validate() {\r\n  var result = { valid: true, message: \"only required if on recurrence_tumour_staging_system is AJCC\" };\r\n  return result;\r\n}\r\n\r\nvalidate();"
              },
              "meta": {
                "core": true
              }
            },
            {
              "name": "recurrence_n_category",
              "description": "The code to represent the stage of cancer defined by which is the extent of the regional lymph node (N) involvement for the cancer based on evidence obtained from clinical assessment parameters determined determined at the time of retreatment for a recurrence or disease progression, according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.",
              "valueType": "string",
              "restrictions": {
                "script": "function validate() {\r\n  var result = { valid: true, message: \"only required if on recurrence_tumour_staging_system is AJCC\" };\r\n  return result;\r\n}\r\n\r\nvalidate();"
              },
              "meta": {
                "core": true
              }
            },
            {
              "name": "recurrence_m_category",
              "description": "The code to represent the stage of cancer defined bythe extent of the distant metastasis (M) for the cancer based on evidence obtained from clinical assessment parameters determined determined at the time of retreatment for a recurrence or disease progression, according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.",
              "valueType": "string",
              "restrictions": {
                "script": "function validate() {\r\n  var result = { valid: true, message: \"only required if on recurrence_tumour_staging_system is AJCC\" };\r\n  return result;\r\n}\r\n\r\nvalidate();"
              },
              "meta": {
                "core": true
              }
            },
            {
              "name": "recurrence_stage_group",
              "description": "The code to represent the stage group of the tumour, as assigned by the reporting recurrence_tumour_staging_system, that indicates the overall prognostic tumour stage (ie. Stage I, Stage II, Stage III etc.) after treatment for patients receiving systemic and/or radiation therapy alone or as a component of their initial treatment, or as neoadjuvant therapy before planned surgery.",
              "valueType": "string",
              "restrictions": {
                "script": "function validate() {\r\n  var result = { valid: true, message: \"only required if on recurrence_tumour_staging_system is AJCC\" };\r\n  return result;\r\n}\r\n\r\nvalidate();"
              },
              "meta": {
                "core": true
              }
            },
            {
              "description": "Specify the tumour staging system used to stage the cancer after treatment for patients receiving systemic and/or radiation therapy alone or as a component of their initial treatment, or as neoadjuvant therapy before planned surgery. This may be represented as ypTNM or ycTNM in the medical report.",
              "name": "posttherapy_tumour_staging_system",
              "valueType": "string",
              "restrictions": {
                "script": "function validate() {\r\n  var result = { valid: true, message: \"depends on disaease_status_at_followup being progression or relapse\" };\r\n  return result;\r\n}\r\n\r\nvalidate();",
                "codeList": [
                  "Binet",
                  "Rai",
                  "FIGO",
                  "Ann Arbor",
                  "Murphy",
                  "Lugano",
                  "AJCC 8th Edition",
                  "AJCC 7th Edition",
                  "AJCC 6th Edition",
                  "AJCC 5th Edition",
                  "AJCC 4th Edition",
                  "AJCC 3rd Edition",
                  "AJCC 2nd Edition",
                  "AJCC 1st Edition"
                ]
              }
            },
            {
              "name": "posttherapy_t_category",
              "description": "The code to represent the extent of the primary tumour (T) based on evidence obtained from clinical assessment parameters determined after treatment for patients receiving systemic and/or radiation therapy alone or as a component of their initial treatment, or as neoadjuvant therapy before planned surgery, according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.",
              "valueType": "string",
              "restrictions": {
                "script": "function validate() {\r\n  var result = { valid: true, message: \"only required if on post_therapy_tumour_staging_system is AJCC\" };\r\n  return result;\r\n}\r\n\r\nvalidate();"
              }
            },
            {
              "name": "posttherapy_n_category",
              "description": "The code to represent the stage of cancer defined by which is the extent of the regional lymph node (N) involvement for the cancer based on evidence obtained from clinical assessment parameters determined determined after treatment for patients receiving systemic and/or radiation therapy alone or as a component of their initial treatment, or as neoadjuvant therapy before planned surgery, according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.",
              "valueType": "string",
              "restrictions": {
                "script": "function validate() {\r\n  var result = { valid: true, message: \"only required if on post_therapy_tumour_staging_system is AJCC\" };\r\n  return result;\r\n}\r\n\r\nvalidate();"
              }
            },
            {
              "name": "posttherapy_m_category",
              "description": "The code to represent the stage of cancer defined bythe extent of the distant metastasis (M) for the cancer based on evidence obtained from clinical assessment parameters determined determined after treatment for patients receiving systemic and/or radiation therapy alone or as a component of their initial treatment, or as neoadjuvant therapy before planned surgery, according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.",
              "valueType": "string",
              "restrictions": {
                "script": "function validate() {\r\n  var result = { valid: true, message: \"only required if on post_therapy_tumour_staging_system is AJCC\" };\r\n  return result;\r\n}\r\n\r\nvalidate();"
              }
            },
            {
              "name": "posttherapy_stage_group",
              "description": "The code to represent the stage group of the tumour, as assigned by the reporting posttherapy_tumour_staging_system, that indicates the overall prognostic tumour stage (ie. Stage I, Stage II, Stage III etc.) after treatment for patients receiving systemic and/or radiation therapy alone or as a component of their initial treatment, or as neoadjuvant therapy before planned surgery.",
              "valueType": "string",
              "restrictions": {
                "script": "function validate() {\r\n  var result = { valid: true, message: \"only required if on post_therapy_tumour_staging_system is AJCC\" };\r\n  return result;\r\n}\r\n\r\nvalidate();"
              }
            }
          ]
        },
        {
          "name": "treatment",
          "description": "The collection of data elements related to a donor's treatment at a specific point in the clinical record.",
          "fields": [
            {
              "name": "program_id",
              "valueType": "string",
              "description": "Unique identifier of the ARGO program.",
              "restrictions": {
                "required": true
              }
            },
            {
              "name": "submitter_donor_id",
              "valueType": "string",
              "description": "Unique identifier of the donor, assigned by the data provider.",
              "restrictions": {
                "required": true,
                "regex": "[A-Za-z0-9\\-\\._]{1,64}"
              }
            },
            {
              "name": "submitter_treatment_id",
              "valueType": "string",
              "description": "Unique identifier of the treatment, as assigned by the data provider.",
              "restrictions": {
                "required": true,
                "regex": "[A-Za-z0-9\\-\\._]{1,64}"
              }
            },
            {
              "name": "treatment_type",
              "description": "Type of the treatment that the donor completed.",
              "valueType": "string",
              "restrictions": {
                "required": true,
                "codeList": [
                  "Chemotherapy",
                  "Ablation",
                  "Bone marrow transplant",
                  "Combined chemo+immunotherapy",
                  "Combined chemo+radiation therapy",
                  "Combined chemo-radiotherapy and surgery",
                  "Endoscopic therapy",
                  "Hormonal therapy",
                  "Immunotherapy",
                  "Monoclonal antibodies (for liquid tumours)",
                  "No treatment",
                  "Other targeting molecular therapy",
                  "Photodynamic therapy",
                  "Radiation therapy",
                  "Stem cell transplant",
                  "Surgical resection"
                ]
              },
              "meta": {
                "core": true
              }
            },
            {
              "name": "age_at_consent_for_treatment",
              "description": "Age of patient when he/she gave their consent for the treatment.",
              "valueType": "integer",
              "restrictions": {
                "units": "years"
              }
            },
            {
              "name": "is_primary_treatment",
              "description": "Was this is the primary treatment following the initial diagnosis?",
              "valueType": "string",
              "restrictions": {
                "required": true,
                "codeList": ["Yes", "No"]
              },
              "meta": {
                "core": true
              }
            },
            {
              "name": "treatment_start_interval",
              "description": "The interval between primary diagnosis and initiation of treatment, in days.",
              "valueType": "integer",
              "restrictions": {
                "required": true
              },
              "meta": {
                "core": true,
                "units": "days"
              }
            },
            {
              "name": "treatment_duration",
              "description": "The duration of treatment regimen, in days",
              "valueType": "integer",
              "restrictions": {
                "required": true
              },
              "meta": {
                "core": true,
                "units": "days"
              }
            },
            {
              "name": "therapeutic_intent",
              "description": "The therapeutic intent, the reason behind the choice of a therapy, of the treatment.",
              "valueType": "string",
              "restrictions": {
                "required": true,
                "codeList": [
                  "Adjuvant",
                  "Concurrent",
                  "Curative",
                  "Neoadjuvant",
                  "Not applicable",
                  "Palliative",
                  "Unknown"
                ]
              },
              "meta": {
                "core": true
              }
            },
            {
              "name": "response_to_therapy",
              "description": "Donors's response to treatment.",
              "valueType": "string",
              "restrictions": {
                "required": true,
                "codeList": [
                  "Complete response",
                  "Disease progression",
                  "NED",
                  "Partial response",
                  "Stable disease"
                ]
              },
              "meta": {
                "core": true
              }
            }
          ]
        },
        {
          "name": "chemotherapy",
          "description": "The collection of data elements describing the details of a chemotherapy treatment completed by a donor.",
          "fields": [
            {
              "name": "program_id",
              "valueType": "string",
              "description": "Unique identifier of the ARGO program.",
              "restrictions": {
                "required": true
              }
            },
            {
              "name": "submitter_donor_id",
              "valueType": "string",
              "description": "Unique identifier of the donor, assigned by the data provider.",
              "restrictions": {
                "required": true,
                "regex": "[A-Za-z0-9\\-\\._]{1,64}"
              }
            },
            {
              "name": "submitter_treatment_id",
              "valueType": "string",
              "description": "Unique identifier of the treatment, as assigned by the data provider.",
              "restrictions": {
                "required": true,
                "regex": "[A-Za-z0-9\\-\\._]{1,64}"
              }
            },
            {
              "name": "chemotherapy_drug_name",
              "description": "Name of agent or drug administered to patient as part of the chemotherapy treatment regimen.",
              "valueType": "string",
              "restrictions": {
                "required": true,
                "codeList": ["Allopurinol", "Dronabinol", "Sucralfate", "Lapatinib"]
              },
              "meta": {
                "core": true
              }
            },
            {
              "name": "chemotherapy_dosage_units",
              "description": "Indicate units used to record chemotherapy drug dosage.",
              "valueType": "string",
              "restrictions": {
                "required": true,
                "codeList": ["mg/m", "IU/m", "g/m", "g/m", "kg"]
              },
              "meta": {
                "core": true
              }
            },
            {
              "name": "cumulative_drug_dosage",
              "description": "Indicate total drug dose in units specified in drug_dosage_units.",
              "valueType": "integer",
              "restrictions": {
                "required": true
              },
              "meta": {
                "core": true
              }
            }
          ]
        },
        {
          "name": "radiation",
          "description": "The collection of data elements describing the details of a radiation treatment completed by a donor.",
          "meta": {
            "parent": "treatment"
          },
          "fields": [
            {
              "name": "program_id",
              "valueType": "string",
              "description": "Unique identifier of the ARGO program.",
              "meta": {
                "primaryId": true,
                "foreignKey": "sample_registration.program_id"
              },
              "restrictions": {
                "required": true,
                "regex": "[A-Za-z0-9\\-\\._]{1,64}"
              }
            },
            {
              "name": "submitter_donor_id",
              "valueType": "string",
              "description": "Unique identifier of the donor, assigned by the data provider.",
              "meta": {
                "primaryId": true,
                "foreignKey": "sample_registration.submitter_donor_id"
              },
              "restrictions": {
                "required": true,
                "regex": "[A-Za-z0-9\\-\\._]{1,64}"
              }
            },
            {
              "name": "submitter_treatment_id",
              "valueType": "string",
              "description": "Unique identifier of the treatment, as assigned by the data provider.",
              "meta": {
                "primaryId": true,
                "foreignKey": "treatment.submitter_treatment_id"
              },
              "restrictions": {
                "required": true,
                "regex": "[A-Za-z0-9\\-\\._]{1,64}"
              }
            },
            {
              "name": "radiation_therapy_modality",
              "description": "Indicate the method of radiation treatment or modality.",
              "valueType": "string",
              "restrictions": {
                "required": true,
                "codeList": ["Electron", "Heavy Ions", "Photon", "Proton"]
              },
              "meta": {
                "core": true
              }
            },
            {
              "name": "application_form",
              "description": "Indicate type of radiation therapy administered.",
              "valueType": "string",
              "restrictions": {
                "required": true,
                "codeList": ["External", "Internal (including Brachytherapy)"]
              },
              "meta": {
                "core": true
              }
            },
            {
              "name": "radiation_therapy_fractions",
              "description": "Indicate the number of total fractions delivered as part of treatment.",
              "valueType": "integer",
              "restrictions": {
                "required": true
              },
              "meta": {
                "core": true
              }
            },
            {
              "name": "radiation_therapy_dosage",
              "description": "Indicate the total dose given in units of Gray (Gy).",
              "valueType": "integer",
              "restrictions": {
                "required": true
              },
              "meta": {
                "core": true
              }
            },
            {
              "name": "anatomical_site_irradiated",
              "description": "Indicate localization site where radiation therapy was administered.",
              "valueType": "string",
              "restrictions": {
                "required": true,
                "codeList": [
                  "Abdomen",
                  "Bone",
                  "Brain",
                  "Extremities",
                  "Head",
                  "Head-Neck",
                  "Liver",
                  "Lung",
                  "Pelvis",
                  "Peritoneum",
                  "Spine",
                  "Thorax"
                ]
              },
              "meta": {
                "core": true
              }
            }
          ]
        },
        {
          "name": "hormone_therapy",
          "description": "The collection of data elements describing the details of a hormone treatment therapy completed by a donor.",
          "meta": {
            "parent": "treatment"
          },
          "fields": [
            {
              "name": "program_id",
              "valueType": "string",
              "description": "Unique identifier of the ARGO program.",
              "meta": {
                "primaryId": true,
                "foreignKey": "sample_registration.program_id"
              },
              "restrictions": {
                "required": true,
                "regex": "[A-Za-z0-9\\-\\._]{1,64}"
              }
            },
            {
              "name": "submitter_donor_id",
              "valueType": "string",
              "description": "Unique identifier of the donor, assigned by the data provider.",
              "meta": {
                "primaryId": true,
                "foreignKey": "sample_registration.submitter_donor_id"
              },
              "restrictions": {
                "required": true,
                "regex": "[A-Za-z0-9\\-\\._]{1,64}"
              }
            },
            {
              "name": "submitter_treatment_id",
              "valueType": "string",
              "description": "Unique identifier of the treatment, as assigned by the data provider.",
              "meta": {
                "primaryId": true,
                "foreignKey": "treatment.submitter_treatment_id"
              },
              "restrictions": {
                "required": true,
                "regex": "[A-Za-z0-9\\-\\._]{1,64}"
              }
            },
            {
              "name": "hormone_therapy_drug_name",
              "description": "Name of agent or drug administered to patient as part of the hormone therapy treatment regimen.",
              "valueType": "string",
              "restrictions": {
                "required": true,
                "codeList": ["Placeholder list 1", "Need list", "Still need it", "Other"]
              },
              "meta": {
                "core": true
              }
            },
            {
              "name": "hormone_drug_dosage_units",
              "description": "Indicate the units used to record hormone drug dosage.",
              "valueType": "string",
              "restrictions": {
                "required": true,
                "codeList": ["mg/m", "IU/m", "g/m", "g/m", "kg "]
              },
              "meta": {
                "core": true
              }
            },
            {
              "name": "cumulative_drug_dosage",
              "description": "Indicate total drug dose in units specified in hormone_drug_dosage_units.",
              "valueType": "integer",
              "restrictions": {
                "required": true
              },
              "meta": {
                "core": true
              }
            }
          ]
        }
      ],
      "name": "ARGO Clinical Submission",
      "version": "1.0"
    },
    {
      "schemas": [
        {
          "name": "sample_registration",
          "description": "Collection of elements required to register the required Donor-Specimen-Sample data to the ARGO Platform. Registration of samples is required before genomic and clinical data submission can proceed.",
          "fields": [
            {
              "name": "program_id",
              "valueType": "string",
              "description": "Unique identifier of the ARGO program.",
              "restrictions": {
                "required": true
              }
            },
            {
              "name": "submitter_donor_id",
              "valueType": "string",
              "description": "Unique identifier of the donor, assigned by the data provider.",
              "restrictions": {
                "required": true,
                "regex": "[A-Za-z0-9\\-\\._]{1,64}"
              }
            },
            {
              "name": "gender",
              "valueType": "string",
              "description": "Description of the donor self-reported gender. Gender is described as the assemblage of properties that distinguish people on the basis of their societal roles.",
              "restrictions": {
                "required": true,
                "codeList": ["Male", "Female", "Other", "Don't Bother"]
              }
            },
            {
              "name": "submitter_specimen_id",
              "valueType": "string",
              "description": "Unique identifier of the specimen, assigned by the data provider.",
              "restrictions": {
                "required": true,
                "regex": "[A-Za-z0-9\\-\\._]{1,64}"
              }
            },
            {
              "name": "specimen_tissue_source",
              "valueType": "string",
              "description": "Tissue source of the biospecimen.",
              "restrictions": {
                "required": true,
                "codeList": [
                  "Blood derived",
                  "Blood derived - bone marrow",
                  "Blood derived - peripheral blood",
                  "Bone marrow",
                  "Buccal cell",
                  "Lymph node",
                  "Solid tissue",
                  "Plasma",
                  "Serum",
                  "Urine",
                  "Cerebrospinal fluid",
                  "Sputum",
                  "Other",
                  "Pleural effusion",
                  "Mononuclear cells from bone marrow",
                  "Saliva",
                  "Skin"
                ]
              }
            },
            {
              "name": "tumour_normal_designation",
              "valueType": "string",
              "description": "Description of the kind of specimen that was collected with respect to tumour/normal tissue origin.",
              "restrictions": {
                "required": true,
                "codeList": [
                  "Normal",
                  "Normal - tissue adjacent to primary tumour",
                  "Primary tumour",
                  "Primary tumour - adjacent to normal",
                  "Primary tumour - additional new primary",
                  "Recurrent tumour",
                  "Metastatic tumour",
                  "Metastatic tumour - metastasis local to lymph node",
                  "Metastatic tumour - metastasis to distant location",
                  "Metastatic tumour - additional metastatic",
                  "Xenograft - derived from primary tumour",
                  "Xenograft - derived from tumour cell line",
                  "Cell line - derived from xenograft tumour",
                  "Cell line - derived from tumour",
                  "Cell line - derived from normal"
                ]
              }
            },
            {
              "name": "submitter_sample_id",
              "valueType": "string",
              "description": "Unique identifier of the sample, assigned by the data provider.",
              "restrictions": {
                "required": true,
                "regex": "[A-Za-z0-9\\-\\._]{1,64}"
              }
            },
            {
              "name": "sample_type",
              "valueType": "string",
              "description": "Description of the type of molecular sample used for testing.",
              "restrictions": {
                "required": true,
                "codeList": [
                  "Total DNA",
                  "Amplified DNA",
                  "ctDNA",
                  "Other DNA enrichments",
                  "Total RNA",
                  "Ribo-Zero RNA",
                  "polyA+ RNA",
                  "Other RNA fractions"
                ]
              }
            }
          ]
        },
        {
          "name": "donor",
          "description": "The collection of data elements related to a specific donor in a specific ICGC-ARGO program.",
          "fields": [
            {
              "name": "program_id",
              "valueType": "string",
              "description": "Unique identifier of the ARGO program.",
              "restrictions": {
                "required": true
              }
            },
            {
              "description": "Unique identifier of the donor, assigned by the data provider.",
              "name": "submitter_donor_id",
              "restrictions": {
                "required": true,
                "regex": "[A-Za-z0-9\\-\\._]{1,64}"
              },
              "valueType": "string"
            },
            {
              "description": "Donors last known state of living or deceased.",
              "name": "vital_status",
              "restrictions": {
                "codeList": ["Alive", "Deceased", "Not reported", "Unknown"],
                "required": true
              },
              "valueType": "string"
            },
            {
              "description": "Description of the cause of a donor's death.",
              "name": "cause_of_death",
              "restrictions": {
                "codeList": ["Died of cancer", "Died of other reasons", "Not reported", "Unknown"]
              },
              "valueType": "string"
            },
            {
              "description": "Interval of how long the donor has survived since primary diagnosis, in days.",
              "meta": {
                "units": "days"
              },
              "name": "survival_time",
              "valueType": "integer"
            }
          ]
        },
        {
          "name": "primary_diagnosis",
          "description": "The collection of data elements related to a donor's primary diagnosis. The primary diagnosis is the first diagnosed case of cancer in a donor.",
          "fields": [
            {
              "name": "program_id",
              "valueType": "string",
              "description": "Unique identifier of the ARGO program.",
              "restrictions": {
                "required": true
              }
            },
            {
              "name": "submitter_donor_id",
              "valueType": "string",
              "description": "Unique identifier of the donor, assigned by the data provider.",
              "restrictions": {
                "required": true,
                "regex": "[A-Za-z0-9\\-\\._]{1,64}"
              }
            },
            {
              "name": "age_at_diagnosis",
              "valueType": "integer",
              "description": "Age that the donor was first diagnosed with cancer, in years.",
              "restrictions": {
                "required": true
              },
              "meta": {
                "units": "years"
              }
            },
            {
              "name": "cancer_type_code",
              "valueType": "string",
              "description": "The code to represent the cancer type using the WHO ICD-10 code (https://icd.who.int/browse10/2016/en#/) classification.",
              "restrictions": {
                "required": true,
                "regex": "[A-Z]{1}[0-9]{2}.[0-9]{0,3}[A-Z]{0,1}$"
              }
            },
            {
              "name": "tumour_staging_system",
              "valueType": "string",
              "description": "Specify the tumour staging system used to stage the cancer at the time of primary diagnosis (prior to treatment).",
              "restrictions": {
                "required": true,
                "codeList": ["Binet", "Rai", "FIGO", "Ann Arbor", "Murphy", "Lugano"]
              }
            },
            {
              "name": "clinical_stage_group",
              "description": "Stage group of the tumour, as assigned by the reporting tumour_staging_system, that indicates the overall prognostic tumour stage (ie. Stage I, Stage II, Stage III etc.).",
              "valueType": "string"
            },
            {
              "name": "stage_suffix",
              "description": "If necessary, use this field to add any applicable stage suffixes. Stage suffixes may apply to certain staging systems such as Ann Arbour staging system where the four stages are divided into 4 categories (A, B, X and E).",
              "valueType": "string"
            },
            {
              "name": "clinical_t_category",
              "description": "The code to represent the extent of the primary tumour (T) based on evidence obtained from clinical assessment parameters determined at time of primary diagnosis and prior to treatment, according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.",
              "valueType": "string"
            },
            {
              "name": "clinical_n_category",
              "description": "The code to represent the stage of cancer defined by which is the extent of the regional lymph node (N) involvement for the cancer based on evidence obtained from clinical assessment parameters determined at time of primary diagnosis and prior to treatment, according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.",
              "valueType": "string"
            },
            {
              "name": "clinical_m_category",
              "description": "The code to represent the stage of cancer defined bythe extent of the distant metastasis (M) for the cancer based on evidence obtained from clinical assessment parameters determined at time of primary diagnosis and prior to treatment, according to criteria based on multiple editions of the AJCC's Cancer Staging Manual. MX is NOT a valid category and cannot be assigned.",
              "valueType": "string"
            },
            {
              "name": "number_lymph_nodes_examined",
              "description": "The total number of lymph nodes tested for the presence of cancer.",
              "valueType": "integer"
            },
            {
              "name": "presenting_symptoms",
              "description": "Indicate presenting symptoms at time of primary diagnosis.",
              "valueType": "string",
              "restrictions": {
                "codeList": ["Back Pain", "Nausea", "None", "Unknown", "Weight Loss"]
              }
            },
            {
              "name": "menopause_status",
              "description": "Indicate the menopause status of the patient at the time of primary diagnosis.",
              "valueType": "string",
              "restrictions": {
                "codeList": ["Perimenopausal", "Postmenopausal", "Premenopausal", "Unknown"]
              }
            }
          ]
        },
        {
          "name": "specimen",
          "description": "The collection of data elements related to a donor's specimen. A specimen is any material sample taken for testing, diagnostic or research purposes.",
          "fields": [
            {
              "name": "program_id",
              "valueType": "string",
              "description": "Unique identifier of the ARGO program.",
              "restrictions": {
                "required": true
              }
            },
            {
              "name": "submitter_donor_id",
              "description": "Unique identifier of the donor, assigned by the data provider.",
              "valueType": "string",
              "restrictions": {
                "required": true,
                "regex": "[A-Za-z0-9\\-\\._]{1,64}"
              }
            },
            {
              "name": "submitter_specimen_id",
              "description": "Unique identifier of the specimen, assigned by the data provider.",
              "valueType": "string",
              "restrictions": {
                "required": true,
                "regex": "[A-Za-z0-9\\-\\._]{1,64}"
              }
            },
            {
              "name": "specimen_acquisition_interval",
              "description": "Interval between primary diagnosis and specimen acquisition, in days.",
              "valueType": "integer",
              "restrictions": {
                "required": true
              },
              "meta": {
                "units": "days"
              }
            },
            {
              "name": "anatomic_location_of_specimen_collection",
              "description": "Anatomic location of a specimen when it was collected.",
              "valueType": "string",
              "restrictions": {
                "required": true,
                "codeList": ["Muscle", "Other", "Wrist"]
              }
            },
            {
              "name": "central_pathology_confirmed",
              "description": "Indicate whether the histologic description of tissue or cells was confirmed by a pathology review of frozen or formalin fixed slide(s) completed after the diagnostic pathology review of the tumour sample used to extract analyte(s).",
              "valueType": "string",
              "restrictions": {
                "required": true,
                "codeList": ["Yes", "No", "Unknown", "Not reported"]
              }
            },
            {
              "name": "tumour_histological_type",
              "description": "The code to represent the histology (morphology) of neoplasms that is usually obtained from a pathology report, according to the International Classification of Diseases for Oncology, 3rd Edition (WHO ICD-O-3).",
              "valueType": "string",
              "restrictions": {
                "required": true,
                "regex": "M-[0-9]{4}/[0-9]{2}$"
              }
            },
            {
              "name": "tumour_grading_system",
              "description": "Specify the tumour staging system used to assess the description of a tumour based on how abnormal the tumour cells and the tumour tissue look under a microscope. Tumour grade is an indicator of how quickly a tumour is likely to  grow.",
              "valueType": "string",
              "restrictions": {
                "required": true,
                "codeList": [
                  "Default",
                  "Gleason",
                  "Nottingham",
                  "Brain cancer",
                  "ISUP",
                  "Lymphoid neoplasms"
                ]
              }
            },
            {
              "name": "tumour_grade",
              "description": "Grade of the tumour as assigned by the reporting tumour_grading_system.",
              "valueType": "string",
              "restrictions": {
                "required": true
              }
            },
            {
              "name": "tumour_staging_system",
              "description": "Specify the tumour staging system used to assess the cancer at the time the tumour specimen was resected. Pathological classification is based on the clinical stage information (acquired before treatment) and supplemented/modified by operative findings and pathological evaluation of the resected specimen.",
              "valueType": "string",
              "restrictions": {
                "required": true,
                "codeList": ["Binet", "Rai", "FIGO", "Ann Arbor", "Murphy", "Lugano"]
              }
            },
            {
              "name": "pathological_stage_group",
              "description": "Specify the tumour stage, based on tumor_staging_system, used to assess the cancer at the time the tumour specimen was resected.",
              "valueType": "string",
              "restrictions": {
                "required": true
              }
            },
            {
              "name": "pathological_t_category",
              "description": "The code to represent the stage of cancer defined by the size or contiguous extension of the primary tumour (T), according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.",
              "valueType": "string"
            },
            {
              "name": "pathological_n_category",
              "description": "The code to represent the stage of cancer defined by whether or not the cancer has reached nearby lymph nodes (N), according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.",
              "valueType": "string"
            },
            {
              "name": "pathological_m_category",
              "description": "The code to represent the stage of cancer defined by whether there are distant metastases (M), meaning spread of cancer to other parts of the body, according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.",
              "valueType": "string"
            },
            {
              "name": "percent_tumour_cells",
              "description": "Indicate a value, in decimals, that represents the percentage of infiltration by tumour cells in a specimen.",
              "valueType": "number",
              "restrictions": {
                "required": true
              }
            },
            {
              "name": "percent_proliferating_cells",
              "description": "Indicate a value, in decimals, that represents the count of proliferating cells determined during pathologic review of the specimen.",
              "valueType": "number",
              "restrictions": {
                "required": true
              }
            },
            {
              "name": "percent_inflammatory_tissue",
              "description": "Indicate a value, in decimals, that represents local response to cellular injury, marked by capillary dilatation, edema and leukocyte infiltration; clinically, inflammation is manifest by redness, heat, pain, swelling and loss of function, with the need to heal damaged tissue.",
              "valueType": "number",
              "restrictions": {
                "required": true
              }
            },
            {
              "name": "percent_stromal_cells",
              "description": "Indicate a value, in decimals, that represents the percentage of reactive cells that are present in a malignant tumour specimen but are not malignant such as fibroblasts, vascular structures, etc.",
              "valueType": "number",
              "restrictions": {
                "required": true
              }
            },
            {
              "name": "percent_necrosis",
              "description": "Indicate a value, in decimals, that represents the percentage of cell death in a malignant tumour specimen.",
              "valueType": "number",
              "restrictions": {
                "required": true
              }
            }
          ]
        }
      ],
      "name": "ARGO Clinical Submission",
      "version": "1.1"
    },
    {
      "schemas": [
        {
          "name": "sample_registration",
          "description": "Collection of elements required to register the required Donor-Specimen-Sample data to the ARGO Platform. Registration of samples is required before genomic and clinical data submission can proceed.",
          "fields": [
            {
              "name": "program_id",
              "valueType": "string",
              "description": "Unique identifier of the ARGO program.",
              "restrictions": {
                "required": true
              }
            },
            {
              "name": "submitter_donor_id",
              "valueType": "string",
              "description": "Unique identifier of the donor, assigned by the data provider.",
              "restrictions": {
                "required": true,
                "regex": "[A-Za-z0-9\\-\\._]{1,64}"
              }
            },
            {
              "name": "gender",
              "valueType": "string",
              "description": "Description of the donor self-reported gender. Gender is described as the assemblage of properties that distinguish people on the basis of their societal roles.",
              "restrictions": {
                "required": true,
                "codeList": ["Male", "Female", "Other"]
              }
            },
            {
              "name": "submitter_specimen_id",
              "valueType": "string",
              "description": "Unique identifier of the specimen, assigned by the data provider.",
              "restrictions": {
                "required": true,
                "regex": "[A-Za-z0-9\\-\\._]{1,64}"
              }
            },
            {
              "name": "specimen_tissue_source",
              "valueType": "string",
              "description": "Tissue source of the biospecimen.",
              "restrictions": {
                "required": true,
                "codeList": [
                  "Blood derived",
                  "Blood derived - bone marrow",
                  "Blood derived - peripheral blood",
                  "Bone marrow",
                  "Buccal cell",
                  "Lymph node",
                  "Solid tissue",
                  "Plasma",
                  "Serum",
                  "Urine",
                  "Cerebrospinal fluid",
                  "Sputum",
                  "Other",
                  "Pleural effusion",
                  "Mononuclear cells from bone marrow",
                  "Saliva",
                  "Skin"
                ]
              }
            },
            {
              "name": "tumour_normal_designation",
              "valueType": "string",
              "description": "Description of the kind of specimen that was collected with respect to tumour/normal tissue origin.",
              "restrictions": {
                "required": true,
                "codeList": [
                  "Normal",
                  "Normal - tissue adjacent to primary tumour",
                  "Primary tumour",
                  "Primary tumour - adjacent to normal",
                  "Primary tumour - additional new primary",
                  "Recurrent tumour",
                  "Metastatic tumour",
                  "Metastatic tumour - metastasis local to lymph node",
                  "Metastatic tumour - metastasis to distant location",
                  "Metastatic tumour - additional metastatic",
                  "Xenograft - derived from primary tumour",
                  "Xenograft - derived from tumour cell line",
                  "Cell line - derived from xenograft tumour",
                  "Cell line - derived from tumour",
                  "Cell line - derived from normal"
                ]
              }
            },
            {
              "name": "submitter_sample_id",
              "valueType": "string",
              "description": "Unique identifier of the sample, assigned by the data provider.",
              "restrictions": {
                "required": true,
                "regex": "[A-Za-z0-9\\-\\._]{1,64}"
              }
            },
            {
              "name": "sample_type",
              "valueType": "string",
              "description": "Description of the type of molecular sample used for testing.",
              "restrictions": {
                "required": true,
                "codeList": [
                  "Total DNA",
                  "Amplified DNA",
                  "ctDNA",
                  "Other DNA enrichments",
                  "Total RNA",
                  "Ribo-Zero RNA",
                  "polyA+ RNA",
                  "Other RNA fractions"
                ]
              }
            }
          ]
        },
        {
          "name": "donor",
          "description": "The collection of data elements related to a specific donor in a specific ICGC-ARGO program.",
          "fields": [
            {
              "name": "program_id",
              "valueType": "string",
              "description": "Unique identifier of the ARGO program.",
              "restrictions": {
                "required": true
              }
            },
            {
              "description": "Unique identifier of the donor, assigned by the data provider.",
              "name": "submitter_donor_id",
              "restrictions": {
                "required": true,
                "regex": "[A-Za-z0-9\\-\\._]{1,64}"
              },
              "valueType": "string"
            },
            {
              "description": "Donors last known state of living or deceased.",
              "name": "vital_status",
              "restrictions": {
                "codeList": ["Alive", "Deceased", "Not reported", "Unknown"],
                "required": true
              },
              "valueType": "string"
            },
            {
              "description": "Description of the cause of a donor's death.",
              "name": "cause_of_death",
              "restrictions": {
                "codeList": ["Died of cancer", "Died of other reasons", "Not reported", "Unknown"]
              },
              "valueType": "string"
            },
            {
              "description": "Interval of how long the donor has survived since primary diagnosis, in days.",
              "meta": {
                "units": "days"
              },
              "name": "survival_time",
              "valueType": "integer"
            }
          ]
        },
        {
          "name": "primary_diagnosis",
          "description": "The collection of data elements related to a donor's primary diagnosis. The primary diagnosis is the first diagnosed case of cancer in a donor.",
          "fields": [
            {
              "name": "program_id",
              "valueType": "string",
              "description": "Unique identifier of the ARGO program.",
              "restrictions": {
                "required": true
              }
            },
            {
              "name": "submitter_donor_id",
              "valueType": "string",
              "description": "Unique identifier of the donor, assigned by the data provider.",
              "restrictions": {
                "required": true,
                "regex": "[A-Za-z0-9\\-\\._]{1,64}"
              }
            },
            {
              "name": "age_at_diagnosis",
              "valueType": "integer",
              "description": "Age that the donor was first diagnosed with cancer, in years.",
              "restrictions": {
                "required": true
              },
              "meta": {
                "units": "years"
              }
            },
            {
              "name": "cancer_type_code",
              "valueType": "string",
              "description": "The code to represent the cancer type using the WHO ICD-10 code (https://icd.who.int/browse10/2016/en#/) classification.",
              "restrictions": {
                "required": true,
                "regex": "[A-Z]{1}[0-9]{2}.[0-9]{0,3}[A-Z]{0,1}$"
              }
            },
            {
              "name": "tumour_staging_system",
              "valueType": "string",
              "description": "Specify the tumour staging system used to stage the cancer at the time of primary diagnosis (prior to treatment).",
              "restrictions": {
                "required": true,
                "codeList": ["Binet", "Rai", "FIGO", "Ann Arbor", "Murphy", "Lugano"]
              }
            },
            {
              "name": "clinical_stage_group",
              "description": "Stage group of the tumour, as assigned by the reporting tumour_staging_system, that indicates the overall prognostic tumour stage (ie. Stage I, Stage II, Stage III etc.).",
              "valueType": "string"
            },
            {
              "name": "stage_suffix",
              "description": "If necessary, use this field to add any applicable stage suffixes. Stage suffixes may apply to certain staging systems such as Ann Arbour staging system where the four stages are divided into 4 categories (A, B, X and E).",
              "valueType": "string"
            },
            {
              "name": "clinical_t_category",
              "description": "The code to represent the extent of the primary tumour (T) based on evidence obtained from clinical assessment parameters determined at time of primary diagnosis and prior to treatment, according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.",
              "valueType": "string"
            },
            {
              "name": "clinical_n_category",
              "description": "The code to represent the stage of cancer defined by which is the extent of the regional lymph node (N) involvement for the cancer based on evidence obtained from clinical assessment parameters determined at time of primary diagnosis and prior to treatment, according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.",
              "valueType": "string"
            },
            {
              "name": "clinical_m_category",
              "description": "The code to represent the stage of cancer defined bythe extent of the distant metastasis (M) for the cancer based on evidence obtained from clinical assessment parameters determined at time of primary diagnosis and prior to treatment, according to criteria based on multiple editions of the AJCC's Cancer Staging Manual. MX is NOT a valid category and cannot be assigned.",
              "valueType": "string"
            },
            {
              "name": "number_lymph_nodes_examined",
              "description": "The total number of lymph nodes tested for the presence of cancer.",
              "valueType": "integer"
            },
            {
              "name": "presenting_symptoms",
              "description": "Indicate presenting symptoms at time of primary diagnosis.",
              "valueType": "string",
              "restrictions": {
                "codeList": ["Back Pain", "Nausea", "None", "Unknown", "Weight Loss"]
              }
            },
            {
              "name": "menopause_status",
              "description": "Indicate the menopause status of the patient at the time of primary diagnosis.",
              "valueType": "string",
              "restrictions": {
                "codeList": ["Perimenopausal", "Postmenopausal", "Premenopausal", "Unknown"]
              }
            }
          ]
        },
        {
          "name": "specimen",
          "description": "The collection of data elements related to a donor's specimen. A specimen is any material sample taken for testing, diagnostic or research purposes.",
          "fields": [
            {
              "name": "program_id",
              "valueType": "string",
              "description": "Unique identifier of the ARGO program.",
              "restrictions": {
                "required": true
              }
            },
            {
              "name": "submitter_donor_id",
              "description": "Unique identifier of the donor, assigned by the data provider.",
              "valueType": "string",
              "restrictions": {
                "required": true,
                "regex": "[A-Za-z0-9\\-\\._]{1,64}"
              }
            },
            {
              "name": "submitter_specimen_id",
              "description": "Unique identifier of the specimen, assigned by the data provider.",
              "valueType": "string",
              "restrictions": {
                "required": true,
                "regex": "[A-Za-z0-9\\-\\._]{1,64}"
              }
            },
            {
              "name": "specimen_acquisition_interval",
              "description": "Interval between primary diagnosis and specimen acquisition, in days.",
              "valueType": "integer",
              "restrictions": {
                "required": true
              },
              "meta": {
                "units": "days"
              }
            },
            {
              "name": "anatomic_location_of_specimen_collection",
              "description": "Anatomic location of a specimen when it was collected.",
              "valueType": "string",
              "restrictions": {
                "required": true,
                "codeList": ["Muscle", "Other", "Wrist"]
              }
            },
            {
              "name": "central_pathology_confirmed",
              "description": "Indicate whether the histologic description of tissue or cells was confirmed by a pathology review of frozen or formalin fixed slide(s) completed after the diagnostic pathology review of the tumour sample used to extract analyte(s).",
              "valueType": "string",
              "restrictions": {
                "required": true,
                "codeList": ["Yes", "No", "Unknown", "Not reported"]
              }
            },
            {
              "name": "tumour_histological_type",
              "description": "The code to represent the histology (morphology) of neoplasms that is usually obtained from a pathology report, according to the International Classification of Diseases for Oncology, 3rd Edition (WHO ICD-O-3).",
              "valueType": "string",
              "restrictions": {
                "required": true,
                "regex": "M-[0-9]{4}/[0-9]{2}$"
              }
            },
            {
              "name": "tumour_grading_system",
              "description": "Specify the tumour staging system used to assess the description of a tumour based on how abnormal the tumour cells and the tumour tissue look under a microscope. Tumour grade is an indicator of how quickly a tumour is likely to  grow.",
              "valueType": "string",
              "restrictions": {
                "required": true,
                "codeList": [
                  "Default",
                  "Gleason",
                  "Nottingham",
                  "Brain cancer",
                  "ISUP",
                  "Lymphoid neoplasms"
                ]
              }
            },
            {
              "name": "tumour_grade",
              "description": "Grade of the tumour as assigned by the reporting tumour_grading_system.",
              "valueType": "string",
              "restrictions": {
                "required": true
              }
            },
            {
              "name": "tumour_staging_system",
              "description": "Specify the tumour staging system used to assess the cancer at the time the tumour specimen was resected. Pathological classification is based on the clinical stage information (acquired before treatment) and supplemented/modified by operative findings and pathological evaluation of the resected specimen.",
              "valueType": "string",
              "restrictions": {
                "required": true,
                "codeList": ["Binet", "Rai", "FIGO", "Ann Arbor", "Murphy", "Lugano"]
              }
            },
            {
              "name": "pathological_stage_group",
              "description": "Specify the tumour stage, based on tumor_staging_system, used to assess the cancer at the time the tumour specimen was resected.",
              "valueType": "string",
              "restrictions": {
                "required": true
              }
            },
            {
              "name": "pathological_t_category",
              "description": "The code to represent the stage of cancer defined by the size or contiguous extension of the primary tumour (T), according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.",
              "valueType": "string"
            },
            {
              "name": "pathological_n_category",
              "description": "The code to represent the stage of cancer defined by whether or not the cancer has reached nearby lymph nodes (N), according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.",
              "valueType": "string"
            },
            {
              "name": "pathological_m_category",
              "description": "The code to represent the stage of cancer defined by whether there are distant metastases (M), meaning spread of cancer to other parts of the body, according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.",
              "valueType": "string"
            },
            {
              "name": "percent_tumour_cells",
              "description": "Indicate a value, in decimals, that represents the percentage of infiltration by tumour cells in a specimen.",
              "valueType": "number",
              "restrictions": {
                "required": true
              }
            },
            {
              "name": "percent_proliferating_cells",
              "description": "Indicate a value, in decimals, that represents the count of proliferating cells determined during pathologic review of the specimen.",
              "valueType": "number",
              "restrictions": {
                "required": true
              }
            },
            {
              "name": "percent_inflammatory_tissue",
              "description": "Indicate a value, in decimals, that represents local response to cellular injury, marked by capillary dilatation, edema and leukocyte infiltration; clinically, inflammation is manifest by redness, heat, pain, swelling and loss of function, with the need to heal damaged tissue.",
              "valueType": "number",
              "restrictions": {
                "required": true
              }
            },
            {
              "name": "percent_stromal_cells",
              "description": "Indicate a value, in decimals, that represents the percentage of reactive cells that are present in a malignant tumour specimen but are not malignant such as fibroblasts, vascular structures, etc.",
              "valueType": "number",
              "restrictions": {
                "required": true
              }
            },
            {
              "name": "percent_necrosis",
              "description": "Indicate a value, in decimals, that represents the percentage of cell death in a malignant tumour specimen.",
              "valueType": "number",
              "restrictions": {
                "required": true
              }
            }
          ]
        }
      ],
      "name": "ARGO Clinical Submission",
      "version": "2.0"
    },
    {
      "schemas": [
        {
          "name": "sample_registration",
          "description": "Collection of elements required to register the required Donor-Specimen-Sample data to the ARGO Platform. Registration of samples is required before genomic and clinical data submission can proceed.",
          "fields": [
            {
              "name": "program_id",
              "valueType": "string",
              "description": "Unique identifier of the ARGO program.",
              "restrictions": {
                "required": true
              }
            },
            {
              "name": "submitter_donor_id",
              "valueType": "string",
              "description": "Unique identifier of the donor, assigned by the data provider.",
              "restrictions": {
                "required": true,
                "regex": "[A-Za-z0-9\\-\\._]{1,64}"
              }
            },
            {
              "name": "gender",
              "valueType": "string",
              "description": "Description of the donor self-reported gender. Gender is described as the assemblage of properties that distinguish people on the basis of their societal roles.",
              "restrictions": {
                "required": true,
                "codeList": ["Male", "Female", "Other"]
              }
            },
            {
              "name": "submitter_specimen_id",
              "valueType": "string",
              "description": "Unique identifier of the specimen, assigned by the data provider.",
              "restrictions": {
                "required": true,
                "regex": "[A-Za-z0-9\\-\\._]{1,64}"
              }
            },
            {
              "name": "specimen_tissue_source",
              "valueType": "string",
              "description": "Tissue source of the biospecimen.",
              "restrictions": {
                "required": true,
                "codeList": [
                  "Blood derived",
                  "Blood derived - bone marrow",
                  "Blood derived - peripheral blood",
                  "Bone marrow",
                  "Buccal cell",
                  "Lymph node",
                  "Solid tissue",
                  "Plasma",
                  "Serum",
                  "Urine",
                  "Cerebrospinal fluid",
                  "Sputum",
                  "Other",
                  "Pleural effusion",
                  "Mononuclear cells from bone marrow",
                  "Saliva",
                  "Skin"
                ]
              }
            },
            {
              "name": "tumour_normal_designation",
              "valueType": "string",
              "description": "Description of the kind of specimen that was collected with respect to tumour/normal tissue origin.",
              "restrictions": {
                "required": true,
                "codeList": [
                  "Normal",
                  "Normal - tissue adjacent to primary tumour",
                  "Primary tumour",
                  "Primary tumour - adjacent to normal",
                  "Primary tumour - additional new primary",
                  "Recurrent tumour",
                  "Metastatic tumour",
                  "Metastatic tumour - metastasis local to lymph node",
                  "Metastatic tumour - metastasis to distant location",
                  "Metastatic tumour - additional metastatic",
                  "Xenograft - derived from primary tumour",
                  "Xenograft - derived from tumour cell line",
                  "Cell line - derived from xenograft tumour",
                  "Cell line - derived from tumour",
                  "Cell line - derived from normal"
                ]
              }
            },
            {
              "name": "submitter_sample_id",
              "valueType": "string",
              "description": "Unique identifier of the sample, assigned by the data provider.",
              "restrictions": {
                "required": true,
                "regex": "[A-Za-z0-9\\-\\._]{1,64}"
              }
            },
            {
              "name": "sample_type",
              "valueType": "string",
              "description": "Description of the type of molecular sample used for testing.",
              "restrictions": {
                "required": true,
                "codeList": [
                  "Total DNA",
                  "Amplified DNA",
                  "ctDNA",
                  "Other DNA enrichments",
                  "Total RNA",
                  "Ribo-Zero RNA",
                  "polyA+ RNA",
                  "Other RNA fractions"
                ]
              }
            }
          ]
        },
        {
          "name": "donor",
          "description": "The collection of data elements related to a specific donor in a specific ICGC-ARGO program.",
          "fields": [
            {
              "name": "program_id",
              "valueType": "string",
              "description": "Unique identifier of the ARGO program.",
              "restrictions": {
                "required": true
              }
            },
            {
              "description": "Unique identifier of the donor, assigned by the data provider.",
              "name": "submitter_donor_id",
              "restrictions": {
                "required": true,
                "regex": "[A-Za-z0-9\\-\\._]{1,64}"
              },
              "valueType": "string"
            },
            {
              "description": "Donors last known state of living or deceased.",
              "name": "vital_status",
              "restrictions": {
                "codeList": ["Alive", "Deceased", "Not reported", "Unknown"],
                "required": true
              },
              "valueType": "string"
            },
            {
              "description": "Description of the cause of a donor's death.",
              "name": "cause_of_death",
              "restrictions": {
                "codeList": ["Died of cancer", "Died of other reasons", "Not reported", "Unknown"]
              },
              "valueType": "string"
            },
            {
              "description": "Interval of how long the donor has survived since primary diagnosis, in days.",
              "meta": {
                "units": "days"
              },
              "name": "survival_time",
              "valueType": "integer"
            }
          ]
        },
        {
          "name": "primary_diagnosis",
          "description": "The collection of data elements related to a donor's primary diagnosis. The primary diagnosis is the first diagnosed case of cancer in a donor.",
          "fields": [
            {
              "name": "program_id",
              "valueType": "string",
              "description": "Unique identifier of the ARGO program.",
              "restrictions": {
                "required": true
              }
            },
            {
              "name": "submitter_donor_id",
              "valueType": "string",
              "description": "Unique identifier of the donor, assigned by the data provider.",
              "restrictions": {
                "required": true,
                "regex": "[A-Za-z0-9\\-\\._]{1,64}"
              }
            },
            {
              "name": "age_at_diagnosis",
              "valueType": "integer",
              "description": "Age that the donor was first diagnosed with cancer, in years.",
              "restrictions": {
                "required": true
              },
              "meta": {
                "units": "years"
              }
            },
            {
              "name": "cancer_type_code",
              "valueType": "string",
              "description": "The code to represent the cancer type using the WHO ICD-10 code (https://icd.who.int/browse10/2016/en#/) classification.",
              "restrictions": {
                "required": true,
                "regex": "[A-Z]{1}[0-9]{2}.[0-9]{0,3}[A-Z]{0,1}$"
              }
            },
            {
              "name": "tumour_staging_system",
              "valueType": "string",
              "description": "Specify the tumour staging system used to stage the cancer at the time of primary diagnosis (prior to treatment).",
              "restrictions": {
                "required": true,
                "codeList": ["Binet", "Rai", "FIGO", "Ann Arbor", "Murphy", "Lugano"]
              }
            },
            {
              "name": "clinical_stage_group",
              "description": "Stage group of the tumour, as assigned by the reporting tumour_staging_system, that indicates the overall prognostic tumour stage (ie. Stage I, Stage II, Stage III etc.).",
              "valueType": "string"
            },
            {
              "name": "stage_suffix",
              "description": "If necessary, use this field to add any applicable stage suffixes. Stage suffixes may apply to certain staging systems such as Ann Arbour staging system where the four stages are divided into 4 categories (A, B, X and E).",
              "valueType": "string"
            },
            {
              "name": "clinical_t_category",
              "description": "The code to represent the extent of the primary tumour (T) based on evidence obtained from clinical assessment parameters determined at time of primary diagnosis and prior to treatment, according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.",
              "valueType": "string"
            },
            {
              "name": "clinical_n_category",
              "description": "The code to represent the stage of cancer defined by which is the extent of the regional lymph node (N) involvement for the cancer based on evidence obtained from clinical assessment parameters determined at time of primary diagnosis and prior to treatment, according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.",
              "valueType": "string"
            },
            {
              "name": "clinical_m_category",
              "description": "The code to represent the stage of cancer defined bythe extent of the distant metastasis (M) for the cancer based on evidence obtained from clinical assessment parameters determined at time of primary diagnosis and prior to treatment, according to criteria based on multiple editions of the AJCC's Cancer Staging Manual. MX is NOT a valid category and cannot be assigned.",
              "valueType": "string"
            },
            {
              "name": "number_lymph_nodes_examined",
              "description": "The total number of lymph nodes tested for the presence of cancer.",
              "valueType": "integer"
            },
            {
              "name": "presenting_symptoms",
              "description": "Indicate presenting symptoms at time of primary diagnosis.",
              "valueType": "string",
              "restrictions": {
                "codeList": ["Back Pain", "Nausea", "None", "Unknown", "Weight Loss"]
              }
            },
            {
              "name": "menopause_status",
              "description": "Indicate the menopause status of the patient at the time of primary diagnosis.",
              "valueType": "string",
              "restrictions": {
                "codeList": ["Perimenopausal", "Postmenopausal", "Premenopausal", "Unknown"]
              }
            }
          ]
        },
        {
          "name": "specimen",
          "description": "The collection of data elements related to a donor's specimen. A specimen is any material sample taken for testing, diagnostic or research purposes.",
          "fields": [
            {
              "name": "program_id",
              "valueType": "string",
              "description": "Unique identifier of the ARGO program.",
              "restrictions": {
                "required": true
              }
            },
            {
              "name": "submitter_donor_id",
              "description": "Unique identifier of the donor, assigned by the data provider.",
              "valueType": "string",
              "restrictions": {
                "required": true,
                "regex": "[A-Za-z0-9\\-\\._]{1,64}"
              }
            },
            {
              "name": "submitter_specimen_id",
              "description": "Unique identifier of the specimen, assigned by the data provider.",
              "valueType": "string",
              "restrictions": {
                "required": true,
                "regex": "[A-Za-z0-9\\-\\._]{1,64}"
              }
            },
            {
              "name": "specimen_acquisition_interval",
              "description": "Interval between primary diagnosis and specimen acquisition, in days.",
              "valueType": "integer",
              "restrictions": {
                "required": true
              },
              "meta": {
                "units": "days"
              }
            },
            {
              "name": "anatomic_location_of_specimen_collection",
              "description": "Anatomic location of a specimen when it was collected.",
              "valueType": "string",
              "restrictions": {
                "required": true,
                "codeList": ["Muscle", "Other", "Wrist"]
              }
            },
            {
              "name": "central_pathology_confirmed",
              "description": "Indicate whether the histologic description of tissue or cells was confirmed by a pathology review of frozen or formalin fixed slide(s) completed after the diagnostic pathology review of the tumour sample used to extract analyte(s).",
              "valueType": "string",
              "restrictions": {
                "required": true,
                "codeList": ["Yes", "No", "Unknown", "Not reported"]
              }
            },
            {
              "name": "tumour_histological_type",
              "description": "The code to represent the histology (morphology) of neoplasms that is usually obtained from a pathology report, according to the International Classification of Diseases for Oncology, 3rd Edition (WHO ICD-O-3).",
              "valueType": "string",
              "restrictions": {
                "required": true,
                "regex": "M-[0-9]{4}/[0-9]{2}$"
              }
            },
            {
              "name": "tumour_grading_system",
              "description": "Specify the tumour staging system used to assess the description of a tumour based on how abnormal the tumour cells and the tumour tissue look under a microscope. Tumour grade is an indicator of how quickly a tumour is likely to  grow.",
              "valueType": "string",
              "restrictions": {
                "required": true,
                "codeList": [
                  "Default",
                  "Gleason",
                  "Nottingham",
                  "Brain cancer",
                  "ISUP",
                  "Lymphoid neoplasms"
                ]
              }
            },
            {
              "name": "tumour_grade",
              "description": "Grade of the tumour as assigned by the reporting tumour_grading_system.",
              "valueType": "string",
              "restrictions": {
                "required": true
              }
            },
            {
              "name": "tumour_staging_system",
              "description": "Specify the tumour staging system used to assess the cancer at the time the tumour specimen was resected. Pathological classification is based on the clinical stage information (acquired before treatment) and supplemented/modified by operative findings and pathological evaluation of the resected specimen.",
              "valueType": "string",
              "restrictions": {
                "required": true,
                "codeList": ["Binet", "Rai", "FIGO", "Ann Arbor", "Murphy", "Lugano"]
              }
            },
            {
              "name": "pathological_stage_group",
              "description": "Specify the tumour stage, based on tumor_staging_system, used to assess the cancer at the time the tumour specimen was resected.",
              "valueType": "string",
              "restrictions": {
                "required": true
              }
            },
            {
              "name": "pathological_t_category",
              "description": "The code to represent the stage of cancer defined by the size or contiguous extension of the primary tumour (T), according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.",
              "valueType": "string"
            },
            {
              "name": "pathological_n_category",
              "description": "The code to represent the stage of cancer defined by whether or not the cancer has reached nearby lymph nodes (N), according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.",
              "valueType": "string"
            },
            {
              "name": "pathological_m_category",
              "description": "The code to represent the stage of cancer defined by whether there are distant metastases (M), meaning spread of cancer to other parts of the body, according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.",
              "valueType": "string"
            },
            {
              "name": "percent_tumour_cells",
              "description": "Indicate a value, in decimals, that represents the percentage of infiltration by tumour cells in a specimen.",
              "valueType": "number",
              "restrictions": {
                "required": true
              }
            },
            {
              "name": "percent_proliferating_cells",
              "description": "Indicate a value, in decimals, that represents the count of proliferating cells determined during pathologic review of the specimen.",
              "valueType": "number",
              "restrictions": {
                "required": true
              }
            },
            {
              "name": "percent_inflammatory_tissue",
              "description": "Indicate a value, in decimals, that represents local response to cellular injury, marked by capillary dilatation, edema and leukocyte infiltration; clinically, inflammation is manifest by redness, heat, pain, swelling and loss of function, with the need to heal damaged tissue.",
              "valueType": "number",
              "restrictions": {
                "required": true
              }
            },
            {
              "name": "percent_stromal_cells",
              "description": "Indicate a value, in decimals, that represents the percentage of reactive cells that are present in a malignant tumour specimen but are not malignant such as fibroblasts, vascular structures, etc.",
              "valueType": "number",
              "restrictions": {
                "required": true
              }
            },
            {
              "name": "percent_necrosis",
              "description": "Indicate a value, in decimals, that represents the percentage of cell death in a malignant tumour specimen.",
              "valueType": "number",
              "restrictions": {
                "required": true
              }
            },
            {
              "name": "treatment",
              "description": "The collection of data elements related to a donor's treatment at a specific point in the clinical record.",
              "fields": [
                {
                  "name": "program_id",
                  "valueType": "string",
                  "description": "Unique identifier of the ARGO program.",
                  "restrictions": {
                    "required": true
                  }
                },
                {
                  "name": "submitter_donor_id",
                  "valueType": "string",
                  "description": "Unique identifier of the donor, assigned by the data provider.",
                  "restrictions": {
                    "required": true,
                    "regex": "[A-Za-z0-9\\-\\._]{1,64}"
                  }
                },
                {
                  "name": "submitter_treatment_id",
                  "valueType": "string",
                  "description": "Unique identifier of the treatment, as assigned by the data provider.",
                  "restrictions": {
                    "required": true,
                    "regex": "[A-Za-z0-9\\-\\._]{1,64}"
                  }
                },
                {
                  "name": "treatment_type",
                  "description": "Type of the treatment that the donor completed.",
                  "valueType": "string",
                  "restrictions": {
                    "required": true,
                    "codeList": [
                      "Chemotherapy",
                      "Ablation",
                      "Bone marrow transplant",
                      "Combined chemo+immunotherapy",
                      "Combined chemo+radiation therapy",
                      "Combined chemo-radiotherapy and surgery",
                      "Endoscopic therapy",
                      "Hormonal therapy",
                      "Immunotherapy",
                      "Monoclonal antibodies (for liquid tumours)",
                      "No treatment",
                      "Other targeting molecular therapy",
                      "Photodynamic therapy",
                      "Radiation therapy",
                      "Stem cell transplant",
                      "Surgical resection"
                    ]
                  },
                  "meta": {
                    "core": true
                  }
                },
                {
                  "name": "age_at_consent_for_treatment",
                  "description": "Age of patient when he/she gave their consent for the treatment.",
                  "valueType": "integer",
                  "restrictions": {
                    "units": "years"
                  }
                },
                {
                  "name": "is_primary_treatment",
                  "description": "Was this is the primary treatment following the initial diagnosis?",
                  "valueType": "string",
                  "restrictions": {
                    "required": true,
                    "codeList": ["Yes", "No"]
                  },
                  "meta": {
                    "core": true
                  }
                },
                {
                  "name": "treatment_start_interval",
                  "description": "The interval between primary diagnosis and initiation of treatment, in days.",
                  "valueType": "integer",
                  "restrictions": {
                    "required": true
                  },
                  "meta": {
                    "core": true,
                    "units": "days"
                  }
                },
                {
                  "name": "treatment_duration",
                  "description": "The duration of treatment regimen, in days",
                  "valueType": "integer",
                  "restrictions": {
                    "required": true
                  },
                  "meta": {
                    "core": true,
                    "units": "days"
                  }
                },
                {
                  "name": "therapeutic_intent",
                  "description": "The therapeutic intent, the reason behind the choice of a therapy, of the treatment.",
                  "valueType": "string",
                  "restrictions": {
                    "required": true,
                    "codeList": [
                      "Adjuvant",
                      "Concurrent",
                      "Curative",
                      "Neoadjuvant",
                      "Not applicable",
                      "Palliative",
                      "Unknown"
                    ]
                  },
                  "meta": {
                    "core": true
                  }
                },
                {
                  "name": "response_to_therapy",
                  "description": "Donors's response to treatment.",
                  "valueType": "string",
                  "restrictions": {
                    "required": true,
                    "codeList": [
                      "Complete response",
                      "Disease progression",
                      "NED",
                      "Partial response",
                      "Stable disease"
                    ]
                  },
                  "meta": {
                    "core": true
                  }
                },
                {
                  "name": "chemotherapy",
                  "description": "The collection of data elements describing the details of a chemotherapy treatment completed by a donor.",
                  "fields": [
                    {
                      "name": "program_id",
                      "valueType": "string",
                      "description": "Unique identifier of the ARGO program.",
                      "restrictions": {
                        "required": true
                      }
                    },
                    {
                      "name": "submitter_donor_id",
                      "valueType": "string",
                      "description": "Unique identifier of the donor, assigned by the data provider.",
                      "restrictions": {
                        "required": true,
                        "regex": "[A-Za-z0-9\\-\\._]{1,64}"
                      }
                    },
                    {
                      "name": "submitter_treatment_id",
                      "valueType": "string",
                      "description": "Unique identifier of the treatment, as assigned by the data provider.",
                      "restrictions": {
                        "required": true,
                        "regex": "[A-Za-z0-9\\-\\._]{1,64}"
                      }
                    },
                    {
                      "name": "chemotherapy_drug_name",
                      "description": "Name of agent or drug administered to patient as part of the chemotherapy treatment regimen.",
                      "valueType": "string",
                      "restrictions": {
                        "required": true,
                        "codeList": ["Allopurinol", "Dronabinol", "Sucralfate", "Lapatinib"]
                      },
                      "meta": {
                        "core": true
                      }
                    },
                    {
                      "name": "chemotherapy_dosage_units",
                      "description": "Indicate units used to record chemotherapy drug dosage.",
                      "valueType": "integer",
                      "restrictions": {
                        "required": true,
                        "codeList": ["mg/m", "IU/m", "g/m", "g/m", "kg"]
                      },
                      "meta": {
                        "core": true
                      }
                    },
                    {
                      "name": "cumulative_drug_dosage",
                      "description": "Indicate total drug dose in units specified in drug_dosage_units.",
                      "valueType": "integer",
                      "restrictions": {
                        "required": true
                      },
                      "meta": {
                        "core": true
                      }
                    }
                  ]
                }
              ]
            }
          ]
        }
      ],
      "name": "ARGO Clinical Submission",
      "version": "3.0"
    }
  ]
}
